Correlates of MS disability assessed in vivo using aggregates of MR quantities.
about
Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopyRevisiting brain atrophy and its relationship to disability in multiple sclerosisLinking structural, metabolic and functional changes in multiple sclerosis.The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the U.S. Glatiramer Acetate Extension Study.Diffusion tensor MRI in multiple sclerosis.Global N-acetylaspartate declines even in benign multiple sclerosisIn vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique.An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.Multiple sclerosis trial designs for the 21st century: building on recent lessons.Clinical trials and clinical practice in multiple sclerosis: conventional and emerging magnetic resonance imaging technologies.Magnetic resonance imaging of multiple sclerosis.Axonal injury in multiple sclerosis.The generation and validation of white matter connectivity importance maps.Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesionsMultiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment.Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study.Novel composite MRI scale correlates highly with disability in multiple sclerosis patients.An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis.Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis.In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.Metabolomic approach to human brain spectroscopy identifies associations between clinical features and the frontal lobe metabolome in multiple sclerosis.In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?Volumetric quantitation by MRI in primary progressive multiple sclerosis: volumes of plaques and atrophy correlated with neurological disability.A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis.Comparison of diffusion-weighted imaging and enhanced T1-weighted sequencing in patients with multiple sclerosis.What do we really see when we look at magnetic resonance images?The role of hereditary spastic paraplegia related genes in multiple sclerosis
P2860
Q24800569-C4C7C051-9CE7-47AA-A7CB-AF77249BB52BQ28729953-9BDE8FC3-B3EA-4092-BAE2-D97425F03D30Q30654880-C3662793-0F81-476B-8B21-03A9A5BA1D35Q31100010-45184ABD-B416-476E-95A6-3ACFB0B08460Q31108864-9497CB0A-62DF-4F00-AB61-AC3E2D346720Q33725131-D213912D-130E-4A74-BBD6-3132AC09ABB5Q33823782-C1E266EB-7102-46E1-AA08-DDCA45F93C4EQ34197065-960DA3D1-4516-48F9-BB90-AA9A70B2CB37Q34463581-4BB75610-E12B-4D2A-8BC0-95D442DEDED0Q34590775-56FC6DCE-FA65-4046-951B-6F69943D91A5Q34965696-48EB3172-0166-4A60-9CEB-707A3ADC380FQ35105813-4871144E-9404-4F83-ACE1-B24752F472A8Q35129729-9AC6C96F-5FED-487B-9ADA-4C2AF597F2BDQ35198492-1C2B31E1-8D90-448A-A92A-CD22557F08BBQ35629319-CC4EB636-6B2B-4EAB-A82C-437D39531DDDQ35869125-260C3ADF-4DC5-4BDB-A86A-5C13C44A60B9Q36307718-4E40FFB0-C650-45FA-85FA-32CF8CC0F02EQ36670128-FFBC5BE5-A336-4132-953C-C58300BE432CQ37014844-B74DCDE3-1BF3-4FF7-A3D2-6E7F0F802990Q37142971-2B8AF33F-78BC-4713-83FB-1C179FD5BBA0Q37296089-437C316F-64C7-454A-88B4-9757D670906DQ37368376-79A25AED-A8E4-4049-979D-016896276ACAQ37388176-D6928FE7-80FC-4E04-8D38-F9E6F0D7E0C8Q37685038-37454B0D-0F43-45E1-9D1C-4FB7481CAAD5Q45998746-01A29BB1-CEAF-4577-8AB4-27FE6257FC0EQ46912034-21A6784B-598D-4F40-9622-A2082BDE9B4AQ48134359-0F87280E-02DE-429D-B334-164C2B04C31EQ48786154-093FF6DF-22FF-420F-85D2-FB24B33505EFQ52097042-DCAE43AE-05CE-4129-A69A-85D1DB9E2B63Q57911875-3A120236-BABD-4A95-BE67-422B76626B4BQ57912335-1F77676E-11EF-4553-B989-A125AFD366B2
P2860
Correlates of MS disability assessed in vivo using aggregates of MR quantities.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Correlates of MS disability assessed in vivo using aggregates of MR quantities.
@en
Correlates of MS disability assessed in vivo using aggregates of MR quantities.
@nl
type
label
Correlates of MS disability assessed in vivo using aggregates of MR quantities.
@en
Correlates of MS disability assessed in vivo using aggregates of MR quantities.
@nl
prefLabel
Correlates of MS disability assessed in vivo using aggregates of MR quantities.
@en
Correlates of MS disability assessed in vivo using aggregates of MR quantities.
@nl
P2093
P356
P1433
P1476
Correlates of MS disability assessed in vivo using aggregates of MR quantities
@en
P2093
G Iannucci
M L Bartolozzi
M P Sormani
N De Stefano
P304
P356
10.1212/WNL.56.10.1331
P407
P577
2001-05-01T00:00:00Z